Stevanato Group S.p.A. (STVN) Insider Santel Buys 4,975 Shares

Luciano Santel purchased 4,975 shares of Stevanato Group S.p.A. (STVN on the NYSE) on June 12, 2026. This transaction follows a week of heavy activity by the company's leadership, with several other insiders also reporting trades in the same period. Santel's move adds a new layer to the shifting ownership structure at the Piombino Dese-based company.

Recent Insider Activity at Stevanato Group

Santel was not the only one active on June 12. Sue-Jean Lin, Karen Flynn, and Elisabetta Magistretti each purchased 4,975 shares on that same day. Meanwhile, Chief Financial Officer Dal Lago Marco sold 7,997 shares on June 12. Earlier in the week, on June 9, Chief Business Strategy Officer Mauro Stocchi both bought and sold ,6586 shares in separate transactions. None of these trades were listed as being part of a Rule 10b5-1 trading plan, which is a tool insiders use to schedule trades in advance.

Stevanato Group Stock Performance

Stevanato Group shares were priced at $18.39 on Friday. The stock has stayed above its 200-day moving average of $18.19, a common technical level used to track long-term price trends. While the stock has climbed significantly from its 52-week low of $12.89, it is still trading well below its yearly high of $27.99. The company's current valuation gives it a price-to-earnings (P/E) ratio of 33.77, though its forward P/E is lower at 23.18, based on expected future profits.

Financial Health and Revenue

In its most recent reporting, Stevanato Group showed annual revenue of $1.23 billion, representing growth of 7.8%. The company maintains a net margin of 10.99% and a return on equity of 9.13%. It also carries a debt-to-equity ratio of 28.73, which measures how much the company uses debt to fund its assets compared to shareholder equity. The next earnings report is expected on November 5, 2026.

Dividend Payments

Stevanato Group pays a dividend to its shareholders. The current dividend yield is 0.32%, and the company has a payout ratio of 11.02%. This ratio shows the portion of earnings a company pays out in dividends versus what it keeps to reinvest in its operations.

Analysts Set New Price Targets

Thirteen analysts currently cover Stevanato Group, and their consensus recommendation is a buy. The average price target among these analysts is $24.47. On September 9, 2026, UBS maintained its neutral rating on the stock but lowered its price target from $28.00 to $23.00. Other analysts have targets ranging from a low of $20.00 to a high of $32.00.

About Stevanato Group S.p.A.

Stevanato Group is an Italian company that specializes in containment and delivery solutions for the biopharma and healthcare industries. They make everything from pre-fillable syringes and glass vials to auto-injectors and diagnostic consumables. Founded in 1949, they serve global pharmaceutical and life sciences companies by providing the high-precision equipment and packaging needed to safely handle and deliver medicines.

What's Ahead for Stevanato Group S.p.A.

Investors often watch insider buying for clues about how a company's leadership views the stock's value. While these June trades provide a look at recent activity, the upcoming November earnings report will likely be the next major catalyst for the stock. This report will reveal whether the company's revenue growth and profit margins are keeping pace with analyst expectations.